AU2013314410B2 - Prebiotic thylakoid composition - Google Patents

Prebiotic thylakoid composition Download PDF

Info

Publication number
AU2013314410B2
AU2013314410B2 AU2013314410A AU2013314410A AU2013314410B2 AU 2013314410 B2 AU2013314410 B2 AU 2013314410B2 AU 2013314410 A AU2013314410 A AU 2013314410A AU 2013314410 A AU2013314410 A AU 2013314410A AU 2013314410 B2 AU2013314410 B2 AU 2013314410B2
Authority
AU
Australia
Prior art keywords
composition
thylakoids
bacteria
use according
enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013314410A
Other languages
English (en)
Other versions
AU2013314410A1 (en
Inventor
Per-Ake Albertsson
Charlotte ERLANSON ALBERTSSON
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THYLABISCO AB
Original Assignee
THYLABISCO AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THYLABISCO AB filed Critical THYLABISCO AB
Publication of AU2013314410A1 publication Critical patent/AU2013314410A1/en
Application granted granted Critical
Publication of AU2013314410B2 publication Critical patent/AU2013314410B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/206—Bacterial extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
AU2013314410A 2012-09-11 2013-09-10 Prebiotic thylakoid composition Active AU2013314410B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1251019 2012-09-11
SE1251019-4 2012-09-11
PCT/EP2013/068656 WO2014040962A1 (en) 2012-09-11 2013-09-10 Prebiotic thylakoid composition

Publications (2)

Publication Number Publication Date
AU2013314410A1 AU2013314410A1 (en) 2015-04-16
AU2013314410B2 true AU2013314410B2 (en) 2017-02-23

Family

ID=49209335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013314410A Active AU2013314410B2 (en) 2012-09-11 2013-09-10 Prebiotic thylakoid composition

Country Status (13)

Country Link
US (1) US20150209396A1 (enExample)
EP (1) EP2895012B1 (enExample)
JP (1) JP6475162B2 (enExample)
KR (1) KR20150053769A (enExample)
CN (1) CN104780783A (enExample)
AU (1) AU2013314410B2 (enExample)
BR (1) BR112015005355A2 (enExample)
CA (1) CA2884281C (enExample)
DK (1) DK2895012T3 (enExample)
ES (1) ES2656619T3 (enExample)
NO (1) NO2895012T3 (enExample)
WO (1) WO2014040962A1 (enExample)
ZA (1) ZA201502431B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015091739A2 (en) * 2013-12-18 2015-06-25 Thylabisco Ab Use of thylakoids to reduce the urge for palatable food
WO2016177682A1 (en) * 2015-05-06 2016-11-10 Snipr Technologies Limited Altering microbial populations & modifying microbiota
JP6551934B2 (ja) * 2015-12-18 2019-07-31 森永乳業株式会社 ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤
JP7244977B2 (ja) * 2016-03-11 2023-03-23 シオノギヘルスケア株式会社 腸内細菌叢調整用組成物
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175899A1 (en) * 2007-01-19 2008-07-24 Ross Mairi R Formulation for promoting sinus health in nasal cavities
WO2012113918A1 (en) * 2011-02-25 2012-08-30 Thylabisco Ab Composition comprising thylakoids for delaying the uptake of molecules

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043217A1 (en) 1998-02-24 1999-09-02 Md Foods A.M.B.A. Use of d-tagatose as a prebiotic food component
US20030165557A1 (en) * 2000-09-19 2003-09-04 Sunstar, Inc. Food, medicine and method relating to Bifidobacterium proliferation promoting action, allergy preventive action and human cholesterol lowering action
JP2006025669A (ja) * 2004-07-14 2006-02-02 Kumamotoken Kajitsu Nogyo Kyodo Kumiai Rengokai 飲料の製造法
US7700139B2 (en) * 2004-12-30 2010-04-20 Commonwealth Scientific And Industrial Research Organization Method and means for improving bowel health
EP3417868A1 (en) 2005-06-10 2018-12-26 Thylabisco AB Composition
JP4819767B2 (ja) * 2006-12-12 2011-11-24 株式会社エス・エフ・シー イグサ青汁
CN101278752A (zh) * 2008-01-29 2008-10-08 梁季鸿 即食卡尼汀天然果蔬饮料干粉系列配方及生产工艺
EP2320919B1 (en) 2008-07-14 2016-03-30 Thylabisco Ab Large-scale process for the preparation of thylakoids
EP3181134B1 (en) * 2009-06-19 2019-10-30 DuPont Nutrition Biosciences ApS Bifidobacteria for treating diabetes and related conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080175899A1 (en) * 2007-01-19 2008-07-24 Ross Mairi R Formulation for promoting sinus health in nasal cavities
WO2012113918A1 (en) * 2011-02-25 2012-08-30 Thylabisco Ab Composition comprising thylakoids for delaying the uptake of molecules

Also Published As

Publication number Publication date
CA2884281C (en) 2021-01-05
CA2884281A1 (en) 2014-03-20
AU2013314410A1 (en) 2015-04-16
BR112015005355A2 (pt) 2017-08-08
WO2014040962A1 (en) 2014-03-20
JP2015533484A (ja) 2015-11-26
ZA201502431B (en) 2017-11-29
DK2895012T3 (en) 2018-01-22
JP6475162B2 (ja) 2019-02-27
EP2895012B1 (en) 2017-10-18
CN104780783A (zh) 2015-07-15
ES2656619T3 (es) 2018-02-27
NO2895012T3 (enExample) 2018-03-17
US20150209396A1 (en) 2015-07-30
KR20150053769A (ko) 2015-05-18
EP2895012A1 (en) 2015-07-22

Similar Documents

Publication Publication Date Title
Lim et al. Lactobacillus sakei OK67 ameliorates high-fat diet–induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression
Li et al. Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota
Sugiharto Role of nutraceuticals in gut health and growth performance of poultry
Márquez-Aguirre et al. Effects of Agave tequilana fructans with different degree of polymerization profiles on the body weight, blood lipids and count of fecal Lactobacilli/Bifidobacteria in obese mice
Ducray et al. Yeast fermentate prebiotic improves intestinal barrier integrity during heat stress by modulation of the gut microbiota in rats
Montelius et al. Feeding spinach thylakoids to rats modulates the gut microbiota, decreases food intake and affects the insulin response
US20200121734A1 (en) Compositions of microbiota and methods related thereto
Elabd et al. Investigating of Moringa oleifera role on gut microbiota composition and inflammation associated with obesity following high fat diet feeding
Önal Darilmaz et al. The effects of inulin as a prebiotic supplement and the synbiotic interactions of probiotics to improve oxalate degrading activity
de Carvalho Marchesin et al. A soy-based probiotic drink modulates the microbiota and reduces body weight gain in diet-induced obese mice
EP2457575B1 (en) New method for obtaining a Lactobacillus reuteri strain useful in medical and veterinary prophylaxis and treatment
CA2884281C (en) Prebiotic thylakoid composition
Cheng et al. Lactobacillus casei-fermented blueberry pomace augments sIgA production in high-fat diet mice by improving intestinal microbiota
Mikelsaar et al. Biodiversity of intestinal lactic acid bacteria in the healthy population
Li et al. Microcapsule of sweet orange essential oil changes gut microbiota in diet-induced obese rats
EP2457576A1 (en) New Lactobacillus reuteri strain useful in medical and veterinary prohylaxis and treatment
Li et al. Apple polysaccharide could promote the growth of Bifidobacterium longum
Xie et al. Effects of Ligustrum robustum on gut microbes and obesity in rats
Ramos-Romero et al. Effects of the combination of ω-3 PUFAs and proanthocyanidins on the gut microbiota of healthy rats
Carmen et al. Postbiotics: Defining the impact of inactivated microbes and their metabolites on promotion of health
Liu et al. Isolation of Bacillus cereus and its probiotic effect on growth performance, antioxidant capacity, and intestinal barrier protection of broilers
Wu et al. Effects of viable Lacticaseibacillus paracasei K56 and its derived postbiotics on obesity and inflammation induced by a high-fat diet
WO2008069102A1 (ja) 炎症性腸疾患予防治療剤
Kuda et al. Effect of food ingredients on susceptible gut indigenous bacteria
Shweta et al. In vitro studies on anti-inflammatory, antioxidant and antihyperglycemic activities of potential probiotic Pediococcus acidilactici NCDC 252

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)